1,843
Views
25
CrossRef citations to date
0
Altmetric
Special Section: A Collection of Articles on Opportunities and Challenges in Utilizing Real-World Data for Clinical Trials and Medical Product Development

The Current Landscape in Biostatistics of Real-World Data and Evidence: Causal Inference Frameworks for Study Design and Analysis

, , , , , , , , , , , , ORCID Icon, , & show all
Pages 43-56 | Received 19 May 2020, Accepted 26 Jan 2021, Published online: 15 Mar 2021

References

  • Abadie, A., and Imbens, G. W. (2016), “Matching on the Estimated Propensity Score,” Econometrica, 84, 781–807. DOI: 10.3982/ECTA11293.
  • Balzer, L. (2017), “Causal Inference in a Big Data World: The Roadmap,” X Congresso Brasileiro de Epidemiologia.
  • Balzer, L. B., Petersen, M. L., and van der Laan, M. J. (2016), “Targeted Estimation and Inference for the Sample Average Treatment Effect in Trials With and Without Pair-Matching,” Statistics in Medicine, 35, 3717–3732. DOI: 10.1002/sim.6965.
  • Bang, H., and Robins, J. M. (2005), “Doubly Robust Estimation in Missing Data and Causal Inference Models,” Biometrics, 61, 962–973. DOI: 10.1111/j.1541-0420.2005.00377.x.
  • Bembom, O., and van der Laan, M. J. (2008), “Analyzing Sequentially Randomized Trials Based on Causal Effect Models for Realistic Individualized Treatment Rules,” Statistics in Medicine, 27, 3689–3716, DOI: 10.1002/sim.3268.
  • Chen, J., Ho, M., Lee, K., Song, Y., Fang, Y., He, W., Irony, T., Jiang, Q., van der Laan, M., Lee, X., Hana Lin, Meng, Z., Mishra-Kalyani, P., Rockhold, F., Wang, H., White, R., and Zink, R. (2020), “The Current Landscape in Biostatistics of Real-World Data and Evidence: Use of RWD/RWE to Inform Clinical Study Design and Analysis (to be submitted).”
  • Colson, K. E., Rudolph, K. E., Zimmerman, S. C., Goin, D. E., Stuart, E. A., van der Laan, M., and Ahern, J. (2016), “Optimizing Matching and Analysis Combinations for Estimating Causal Effects,” Scientific Reports, 6, 23222. DOI: 10.1038/srep23222.
  • Crown, W. H. (2019), “Real-World Evidence, Causal Inference, and Machine Learning,” Value in Health, 22, 587–592. DOI: 10.1016/j.jval.2019.03.001.
  • de los Angeles Resa, M., and Zubizarreta, J. R. (2016), “Evaluation of Subset Matching Methods and Forms of Covariate Balance,” Statistics in Medicine, 35, 4961–4979. DOI: 10.1002/sim.7036.
  • Díaz, I., and van der Laan, M. J. (2013), “Sensitivity Analysis for Causal Inference Under Unmeasured Confounding and Measurement Error Problems,” The International Journal of Biostatistics, 9, 149–160. DOI: 10.1515/ijb-2013-0004.
  • Díaz, I., Luedtke, A. R., and van der Laan, M. J. (2018), “Sensitivity Analysis,” in Targeted Learning in Data Science, eds. M. J. Van der Laan and R. Sherri, Switzerland: Springer, pp. 511–522.
  • Ewald, H., Speich, B., Ladanie, A., Bucher, H. C., Ioannidis, J. P. A., and Hemkens, L. G. (2019), “Marginal Structural Models and Other Analyses Allow Multiple Estimates of Treatment Effects in Randomized Clinical Trials: Meta-Epidemiological Analysis,” Journal of Clinical Epidemiology, 107, 12–26. DOI: 10.1016/j.jclinepi.2018.11.001.
  • Fang, Y., Wang, H., and He, W. (2020), “A Statistical Roadmap for Journey From Real-World Data to Real-World Evidence,” Therapeutic Innovation & Regulatory Science, 54, 749–757.
  • FDA (2013), “Best Practices for Conducting and Reporting Pharmacoepidemiologic Safety Studies Using Electronic Healthcare Data Sets.”
  • FDA (2017a), “PDUFA Reauthorization Performance Goals and Procedures Fiscal Years 2018 Through 2022.”
  • FDA (2017b), “Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices—Guidance for Industry and Food and Drug Administration Staff,” FDA.
  • FDA (2018), “Framework for FDA’s Real-World Evidence Program,” FDA.
  • Frangakis, C. E., and Rubin, D. B. (2002), “Principal Stratification in Causal Inference,” Biometrics, 58, 21–29. DOI: 10.1111/j.0006-341x.2002.00021.x.
  • Glass, T. A., Goodman, S. N., Hernán, M. A., and Samet, J. M. (2013), “Causal Inference in Public Health,” Annual Review of Public Health, 34, 61–75, DOI: 10.1146/annurev-publhealth-031811-124606.
  • Goodman, S. N., Schneeweiss, S., and Baiocchi, M. (2017), “Using Design Thinking to Differentiate Useful From Misleading Evidence in Observational Research,” JAMA, 317, 705–707. DOI: 10.1001/jama.2016.19970.
  • Greenland, S., and Pearl, J. (2017), “Causal Diagrams,” Wiley StatsRef: Statistics Reference Online, DOI: 10.1002/9781118445112.stat03732.pub2.
  • Hansen, B. B. (2008), “The Prognostic Analogue of the Propensity Score,” Biometrika, 95, 481–488. DOI: 10.1093/biomet/asn004.
  • Herrmann, H. C., Thourani, V. H., Kodali, S. K., Makkar, R. R., Szeto, W. Y., Anwaruddin, S., Desai, N., Lim, S., Malaisrie, S. C., and Kereiakes, D. J. (2016), “One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis,” Circulation, 134, 130–140. DOI: 10.1161/CIRCULATIONAHA.116.022797.
  • ICH (2019), “Addendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guideline on Statistical Principles for Clinical Trials E9(R1),” International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.
  • Imbens, G. W., and Rubin, D. B. (2017), “Rubin Causal Model,” in The New Palgrave Dictionary of Economics, eds. S. Durlauf and L. E. Blum, London: Palgrave Macmillan UK, pp. 1–10.
  • Lendle, S. D., Fireman, B., and van der Laan, M. J. (2015), “Balancing Score Adjusted Targeted Minimum Loss-based Estimation,” Journal of Causal Inference, 3, 139–155. DOI: 10.1515/jci-2012-0012.
  • Levenson, M. S. (2020), “Regulatory-Grade Clinical Trial Design Using Real-World Data,” Clinical Trials, 17, 377–382. DOI: 10.1177/1740774520905576.
  • Li, F., Morgan, K. L., and Zaslavsky, A. M. (2018), “Balancing Covariates via Propensity Score Weighting,” Journal of the American Statistical Association, 113, 390–400. DOI: 10.1080/01621459.2016.1260466.
  • Mansournia, M. A., and Altman, D. G. (2016), “Inverse Probability Weighting,” BMJ, 352, i189.
  • Mao, H., Li, L., and Greene, T. (2019), “Propensity Score Weighting Analysis and Treatment Effect Discovery,” Statistical Methods in Medical Research, 28, 2439–2454. DOI: 10.1177/0962280218781171.
  • Neyman, J. (1923), “On the Application of Probability Theory to Agricultural Experiments. Essay on Principles. Section 9,” Annals of Agricultural Sciences, 1–51.
  • Pearl, J. (1995), “Causal Diagrams for Empirical Research,” Biometrika, 82, 669–688. DOI: 10.1093/biomet/82.4.669.
  • Pearl, J. (2009a), Causality: Models, Reasoning, and Inference, Cambridge University Press, New York.
  • Pearl, J. (2009b), “Letter to the Editor: Remarks on the Method of Propensity Score.”
  • Pearl, J. (2009c), “Remarks on the Method of Propensity Score,” Statistics in Medicine, 28, 1415–1416; author reply 1420–1423.
  • Pearl, J., Glymour, M., and Jewell, N. (2016), Causal Inference in Statistics: A Primer, West Sussex, UK: Wiley.
  • Petersen, M. L., and van der Laan, M. J. (2014), “Causal Models and Learning From Data: Integrating Causal Modeling and Statistical Estimation,” Epidemiology, 25, 418. DOI: 10.1097/EDE.0000000000000078.
  • Petersen, M., Schwab, J., Gruber, S., Blaser, N., Schomaker, M., and van der Laan, M. (2014), “Targeted Maximum Likelihood Estimation for Dynamic and Static Longitudinal Marginal Structural Working Models,” Journal of Causal Inference, 2, 147–185. DOI: 10.1515/jci-2013-0007.
  • Robins, J. (1986), “A New Approach to Causal Inference in Mortality Studies With a Sustained Exposure Period—Application to Control of the Healthy Worker Survivor Effect,” Mathematical Modelling, 7, 1393–1512. DOI: 10.1016/0270-0255(86)90088-6.
  • Robins, J. M., Hernán, M. Á., and Brumback, B. (2000), “Marginal Structural Models and Causal Inference in Epidemiology,” Epidemiology, 11, 550.
  • Rosenbaum, P. R., and Rubin, D. B. (1983), “The Central Role of the Propensity Score in Observational Studies for Causal Effects,” Biometrika, 70, 41–55. DOI: 10.1093/biomet/70.1.41.
  • Rosenbaum, P. R., and Rubin, D. B. (1985), “Constructing a Control Group Using Multivariate Matched Sampling Methods That Incorporate the Propensity Score,” The American Statistician, 39, 33–38.
  • Rotnitzky, A., and Robins, J. M. (2014), “Inverse Probability Weighting in Survival Analysis,” Wiley StatsRef: Statistics Reference Online, DOI: 10.1002/9781118445112.stat06031.
  • Rubin, D. B. (1973), “Matching to Remove Bias in Observational Studies,” Biometrics, 29, 159–183. DOI: 10.2307/2529684.
  • Rubin, D. B. (2005), “Basic Concepts of Statistical Inference for Causal Effects in Experiments and Observational Studies,” 140.
  • Rubin, D. B. (2007), “The Design Versus the Analysis of Observational Studies for Causal Effects: Parallels With the Design of Randomized Trials,” Statistics in Medicine, 26, 20–36.
  • Rubin, D. B. (2008), “For Objective Causal Inference, Design Trumps Analysis,” The Annals of Applied Statistics, 2, 808–840.
  • Rubin, D. B., and Stuart, E. A. (2005), “Matching With Multiple Control Groups, and Adjusting for Group Differences,” in 2005 Proceedings of the American Statistical Association, p. 12.
  • Saddiki, H., and Balzer, L. B. (2018), “A Primer on Causality in Data Science,” arXiv no. 1809.02408.
  • Stuart, E. A. (2010), “Matching Methods for Causal Inference: A Review and a Look Forward,” Statistical Science, 25, 1–21. DOI: 10.1214/09-STS313.
  • Stuart, E. A., Cole, S. R., Bradshaw, C. P., and Leaf, P. J. (2011), “The Use of Propensity Scores to Assess the Generalizability of Results From Randomized Trials,” Journal of the Royal Statistical Society, Series A, 174, 369–386. DOI: 10.1111/j.1467-985X.2010.00673.x.
  • Stuart, E. A., Huskamp, H. A., Duckworth, K., Simmons, J., Song, Z., Chernew, M. E., and Barry, C. L. (2014), “Using Propensity Scores in Difference-in-Differences Models to Estimate the Effects of a Policy Change,” Health Services and Outcomes Research Methodology, 14, 166–182. DOI: 10.1007/s10742-014-0123-z.
  • Stuart, E. A., Lee, B. K., and Leacy, F. P. (2013), “Prognostic Score-Based Balance Measures Can Be a Useful Diagnostic for Propensity Score Methods in Comparative Effectiveness Research,” Journal of Clinical Epidemiology, 66, S84–S90.e1. DOI: 10.1016/j.jclinepi.2013.01.013.
  • van der Laan, M. J., and Robins, J. (2003), Unified Methods for Censored Longitudinal Data and Causality, New York: Springer-Verlag.
  • van der Laan, M. J., and Rose, S. (2011), Targeted Learning: Causal Inference for Observational and Experimental Data, New York: Springer-Verlag.
  • van der Laan, M. J., and Rose, S. (2018), Targeted Learning in Data Science, Cham: Springer.
  • VanderWeele, T. J. (2019), “Principles of Confounder Selection,” European Journal of Epidemiology, 34, 211–219. DOI: 10.1007/s10654-019-00494-6.
  • Wang, Y., Petersen, M., Bangsberg, D., and Laan, M. van der (2006), “Diagnosing Bias in the Inverse Probability of Treatment Weighted Estimator Resulting from Violation of Experimental Treatment Assignment,” U.C. Berkeley Division of Biostatistics Working Paper Series.
  • Yue, L. Q. (2018), “Leveraging Real-World Evidence Derived From Patient Registries for Premarket Medical Device Regulatory Decision-Making,” Statistics in Biopharmaceutical Research, 10, 98–103. DOI: 10.1080/19466315.2017.1422436.
  • Yue, L. Q., Lu, N., and Xu, Y. (2014), “Designing Premarket Observational Comparative Studies Using Existing Data as Controls: Challenges and Opportunities,” Journal of Biopharmaceutical Statistics, 24, 994–1010. DOI: 10.1080/10543406.2014.926367.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.